Trial Profile
Efficacy of intravitreal ranibizumab in patients with diabetic macular edema who failed to intravitreal bevacizumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2017
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Diabetic macular oedema
- Focus Therapeutic Use
- 23 Feb 2017 New trial record